Celestica: A Cheaper Ticket To The AI Infrastructure Boom

Celestica shares have fallen 27% since the author's prior coverage, versus a 2% gain for the benchmark. Despite the underperformance, accelerating institutional demand is presented as evidence of sustained investor interest. The article argues CLS trades at an unjustified discount to peers based on its forward P/E and expected revenue and EPS growth.

Analysis

CLS’s valuation case is only durable if earnings growth is being driven by higher-value data-center integration and networking programs rather than a cyclical recovery in traditional electronics manufacturing. The relevant peer set is not broad EMS alone: a sustained mix shift would justify convergence toward Jabil (JBL) and Sanmina (SANM), while evidence of low-margin program ramping would keep the discount intact. The next two quarters matter more than institutional ownership data; backlog conversion, program-level gross-margin mix, and customer concentration will determine whether incremental revenue carries operating leverage.

The 27% drawdown creates an asymmetric setup only if estimates have stabilized. A crowded institutional bid can amplify upside on a clean earnings print, but it also raises downside risk if a single hyperscale/customer order is delayed or working-capital consumption exceeds expectations; EMS names can de-rate quickly when inventory and receivables rise faster than sales. Over the next 1-3 months, monitor consensus FY revenue/EPS revisions and short interest rather than treating ownership accumulation as an independent catalyst. Over 6-18 months, the key structural risk is that AI hardware customers internalize integration or dual-source production, limiting margin expansion even if sector demand remains strong.

Key Decisions for Investors

• Initiate a starter long CLS only after the next earnings release confirms revenue growth with stable-to-higher gross margin and no material increase in customer concentration; target 15-20% upside from multiple normalization, with a 8-10% stop if guidance or margins miss.
• Express the thesis as long CLS / short SANM in equal dollar amounts if CLS’s forward EPS growth remains at least 10 percentage points above SANM’s while its forward P/E discount persists; reassess if CLS guides to weaker cash conversion or SANM closes the growth gap.
• Do not add solely on institutional-demand disclosures. Set an alert for downward consensus EPS revisions exceeding 5% or days-sales-outstanding/inventory growth materially above revenue growth; either would invalidate the operating-leverage thesis and warrant exiting longs.
• For event-risk control, use a defined-risk post-earnings structure rather than pre-earnings upside calls: buy 3-6 month CLS call spreads only after guidance validation, with strikes sized to capture a 10-15% rebound while limiting exposure to a customer-program reset.